Best practice for statisticians in industry sponsored trials

doi:10.1136/bmj.d1636

From trainee to consultant, BMJ Group offers doctors around the world tailored information, special events, learning resources and recruitment services at every step along their career path.

... by doctors, for doctors, for patients
We are open for entries!

Online learning

BMJ Learning

High-quality CME / CPD for doctors and other healthcare professionals. BMJ Learning features hundreds of accredited, peer-reviewed learning modules in text, video, and audio formats. Find out more

Courses and Qualifications

BMJ Masterclasses

BMJ Masterclasses, led by experts, help clinicians to use the latest evidence and recent guidelines in practice and meet their CPD/CME requirements. Find out more

Exam Preparation

The leading provider of online exam preparation, helping over 167,000 healthcare professionals to pass their exams. Find out more

onExamination

Search all BMJ comment articles:

From

Limit by

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Steven A Julious, reader in medical statistics1,
Stephen Pyke, VP statistics, Pfizer, and chair, Statisticians in the Pharmaceutical Industry (PSI)2,
Sara Hughes, head of statistics, ViiV Healthcare, and former chair, Statisticians in the Pharmaceutical Industry (PSI)3

¹Medical Statistics Group, School of Health and Related Research, University of Sheffield, Sheffield S1 4DA, UK
²Pfizer, Sandwich, Kent CT13 9NJ, UK
³ViiV Healthcare, Brentford, Middlesex TW8 9GS, UK

S.A.Julious{at}sheffield.ac.uk

In light of CONSORT 2010,1 the recently proposed best practice for statisticians in reporting industry sponsored trials should be highlighted.2 The eight recommendations below were explained in two accompanying articles.3 4 A forum for editors, industry, and academia to discuss the issues raised would be beneficial.